These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7426252)

  • 1. Effect of experimental cholestasis on neuromuscular blocking drugs in cats.
    Westra P; Houwertjes MC; de Lange AR; Scaf AH; Hindriks FR; Agoston S
    Br J Anaesth; 1980 Aug; 52(8):747-57. PubMed ID: 7426252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal disposition of pancuronium and gallamine in patients with extrahepatic cholestasis.
    Westra P; Vermeer GA; de Lange AR; Scaf AH; Meijer DK; Wesseling H
    Br J Anaesth; 1981 Apr; 53(4):331-8. PubMed ID: 7225266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile salts and neuromuscular blocking agents.
    Westra P; Houwertjes MC; Wesseling H; Meijer DK
    Br J Anaesth; 1981 Apr; 53(4):407-15. PubMed ID: 6112011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation by bile salts of the duration of action of a steroidal neuromuscular blocking agent.
    Vonk RJ; Westra P; Houwertjes MC; Agoston S
    Br J Anaesth; 1979 Aug; 51(8):719-23. PubMed ID: 497068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying the prolonged duration of action of muscle relaxants caused by extrahepatic cholestasis.
    Westra P; Keulemans GT; Houwertjes MC; Hardonk MJ; Meijer DK
    Br J Anaesth; 1981 Mar; 53(3):217-27. PubMed ID: 6110432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between disposition and duration of action of congeneric series of steroidal neuromuscular blocking agents.
    Agoston S; Crul EJ; Kersten UW; Houwertjes MC; Scaf AH
    Acta Anaesthesiol Scand; 1977; 21(1):24-30. PubMed ID: 842267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the pharmacology of Org 6338 (2beta, 16beta-dipiperidino - 5alpha - androstan - 3alpha - ol acetate dimethobromide), a new steroidal neuromuscular blocking agent.
    Sugrue MF; Duff N; McIndewar I
    J Pharm Pharmacol; 1975 Oct; 27(10):721-7. PubMed ID: 52704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil intensifies neuromuscular blockade produced by gallamine and pancuronium at the chick neuromuscular junction.
    Wali FA
    Pharmacol Res Commun; 1986 Jun; 18(6):529-41. PubMed ID: 3749243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the neuromuscular blocking properties of ORG NC 45 and pancuronium in the rat, cat and rhesus monkey.
    Durant NN; Houwertjes MC; Crul JF
    Br J Anaesth; 1980 Aug; 52(8):723-30. PubMed ID: 6107096
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of ORG NC 45 compared with other non-depolarizing neuromuscular blocking drugs.
    Marshall IG; Agoston S; Booij LH; Durant NN; Foldes FF
    Br J Anaesth; 1980; 52 Suppl 1():11S-19S. PubMed ID: 6158961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for determining the influence of hepatic uptake of nondepolarizing muscle relaxants in the pig.
    Motsch J; Hennis PJ; Zimmermann FA; Agoston S
    Anesthesiology; 1989 Jan; 70(1):128-33. PubMed ID: 2563214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.
    Son SL; Waud BE; Waud DR
    Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical antagonism of neuromuscular block by vecuronium metabolites.
    Ohta Y
    Acta Med Okayama; 1985 Dec; 39(6):471-80. PubMed ID: 2868610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.